SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Nokia Oyj engages in the provision of network infrastructure, technology, and software services. It operates through the following segments: Mobile Networks, Network Infrastructure, Cloud and Network Services, and Nokia Technologies. The Mobile Networks segment offers technologies for Radio Access Networks (RAN) as well as Microwave Radio Links (MWR) for transport networks. The Network Infrastructure serves communication service providers, enterprises, webscales and public sector customers. The Cloud and Network Services segment builds around software and the cloud and is focused on driving leadership in cloud-native software and as-a-service delivery models, as demand for critical networks accelerates; and with strong market positions in communications software, private wireless networks, and cognitive (or intelligent) services. The Nokia Technologies segment, building on decades of innovation and R&D leadership in technologies used in virtually all mobile devices used today, is expanding the Nokia patent licensing business, reintroducing the Nokia brand to smartphones through brand licensing, and establishing a technology licensing business. The company was founded by Fredrik Idestam in 1865 and is headquartered in Espoo, Finland.

Nokia Corp - ADR

Nokia Corp

Nokia is trending as investors react to the company's expanded global AI-RAN trials on NVIDIA platforms and a partnership with C3IA to support UK defense digital transformation. While some traders view the recent price volatility as a manipulation-driven shakeout, others are bullish on the company's long-term position in the AI infrastructure and optical networking markets.

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care and Rare Disease segments. The Diabetes and Obesity Care segment includes diabetes, obesity, cardiovascular, and emerging therapy areas. The Rare Disease segment refers to rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1923 is headquartered in Bagsværd, Denmark.

Novo Nordisk - ADR

Novo Nordisk A/S

Novo Nordisk is trending as traders react to a wave of analyst downgrades citing concerns over pipeline development, mid-term growth, and competitive pressure from Eli Lilly. While the community remains divided between those viewing the current valuation as a generational buying opportunity and those frustrated by the stock's persistent downward price action, many investors are focused on the upcoming Capital Markets Day as a critical catalyst for management to reset the narrative.

Intel Corp. engages in the design, manufacture, and sale of computer products and technologies. It delivers computer, networking, data storage, and communications platforms. The firm operates through the following segments: Client Computing Group (CCG), Data Center and AI (DCAI), Intel Foundry Services (IFS), and All Other. The CCG segment consists of platforms designed for notebooks, 2-in-1 systems, desktops, tablets, phones, wireless and wired connectivity products, and mobile communication components. The DCAI segment delivers solutions to cloud service providers and enterprise customers, along with silicon devices for communications service providers and high-performance computing customers. The IFS segment refers to full stack solutions created from the foundry industry ecosystem. The All Other segment represents results from other non-reportable segments and corporate-related charges. The company was founded by Robert Norton Noyce and Gordon Earle Moore on July 18, 1968, and is headquartered in Santa Clara, CA.

Intel Corp.

Intel Corp

Intel and SK Hynix are trending following reports that the companies are in exploratory talks to potentially manufacture memory chips in the United States, including options to lease part of Intel's Ohio campus or form a joint venture. While SK Hynix has stated that no plans have been finalized, the community remains divided between those viewing the potential deal as a major catalyst for Intel's foundry business and those treating the reports as speculation or rumors.

Critical Metals Corp. engages in the mining, exploration, and development of lithium metals. It owns Wolfsberg Project and Tanbreez Project. The company was founded on October 24, 2022 and is headquartered in British Virgin Islands.

Critical Metals Corp.

Critical Metals Corp. is trending as investors react to the company's progress in its $835 million merger with European Lithium, including recent court approvals that set the stage for upcoming shareholder votes. While bulls highlight potential catalysts like the Tanbreez rare-earth project and broader sector tailwinds, debate persists on message boards regarding management's project execution and project valuation.

Starbucks Corp. engages in the production, marketing, and retailing of specialty coffee. It operates through the following segments: North America, International, and Channel Development. The North America segment focuses on the United States and Canada. The International segment is involved in China, Japan, Asia Pacific, Europe, Middle East, Africa, Latin America, and Caribbean. The Channel Development segment includes roasted whole bean and ground coffees, Seattle’s Best Coffee, and Teavana-branded single-serve products. The company was founded by Jerry Baldwin and Howard D. Schultz on November 4, 1985, and is headquartered in Seattle, WA.

Starbucks Corp.

Starbucks Corp

Starbucks is trending as retail sentiment remains divided over the sustainability of its turnaround efforts and valuation, with traders debating whether its recent price action presents a buying opportunity or a signal of deeper structural weakness. Discussions frequently weigh the impact of rising operational costs, consumer spending pressure, and emerging competition against management's ongoing initiatives to improve store experience and efficiency.

Cipher Digital, Inc. operates as a Bitcoin mining ecosystem in the United States. The firm is developing a cryptocurrency business. The company was founded in 2021 and is headquartered in New York, NY.

Cipher Digital Inc.

Cipher Digital is trending as investors react to the company's recent disclosure of conditional classifications for a significant portion of its Texas project pipeline within ERCOT's Batch Zero process. While some traders view the 3.2 GW of conditionally classified projects as a positive de-risking event, others express uncertainty and frustration regarding the lack of site-specific details, contributing to significant volatility in the share price.

Netflix, Inc. engages in providing entertainment services. It also offers activities for leisure time, entertainment video, video gaming, and other sources of entertainment. It operates through the United States and International geographic segments. The company was founded by Marc Randolph and Wilmot Reed Hastings on August 29, 1997 and is headquartered in Los Gatos, CA.

Netflix Inc.

Netflix Inc

Netflix is facing downward pressure following reports of announced subscription price increases in international markets, with traders debating whether this reflects strong pricing power or risks of subscriber churn. While some investors view the pullback as a buying opportunity, others express frustration over management strategy and lack of share price momentum.

Oscar Health, Inc. is a healthcare insurance company, which serves its customers through a technology platform. It offers individual and family, small group and medicare advantage plans, and technology platform to others within the provider and payor space. The company was founded by Mario Tobias Schlosser, Kevin Nazemi, and Joshua Kushner on October 25, 2012 and is headquartered in New York, NY.

Oscar Health Inc - Ordinary Shares - Class A

Oscar Health is trending as the community anticipates the upcoming Investor Day, with discussions centering on the company's long-term financial targets and potential growth. Traders are also actively debating recent price action and technical setups, including speculation about potential acquisition interest.

XRP is a decentralized digital asset and the native token of the XRP Ledger, a Layer 1 blockchain designed for high-performance global payments. Its primary value proposition is offering a fast, cost-effective alternative to traditional banking systems by enabling near-instant cross-border settlements that finalize in three to five seconds. By serving as a neutral bridge asset between different fiat currencies, it helps financial institutions lower liquidity costs and eliminates the need for pre-funded accounts.  The network is unique because it utilizes a federated consensus protocol instead of energy-intensive mining or staking. This system achieves deterministic finality through a Unique Node List of trusted validators who must reach an eighty percent agreement threshold to permanently record transactions. This infrastructure supports a sustained throughput of 1,500 transactions per second and includes a built-in decentralized exchange that allows for the automated trading of any tokenized asset without intermediaries.  The project traces its origins back to 2004 with Ryan Fugger before being co-founded in its modern form by Jed McCaleb and Chris Larsen. The company, now known as Ripple, works with major financial institutions as partners and investors to build global payment solutions. To protect the network from spam, a small amount of XRP is burned during every transaction, and the token is further utilized by institutions as collateral to access traditional markets and manage digital asset infrastructure.  Institutional adoption of the asset reached a major milestone in November 2025 when the SEC approved the first wave of spot XRP ETFs. These products, offered by major issuers including Bitwise, Grayscale, 21Shares, Canary Capital, and Franklin Templeton, are now listed on prominent exchanges like the NYSE Arca, Nasdaq, and Cboe BZX. While Ripple remains a key contributor to the ecosystem, the underlying XRP Ledger continues to operate as an open-source and decentralized network.

Ripple

XRP is experiencing heightened volatility and selling pressure following the failure of the U.S. Senate to reach the 60-vote threshold required to advance the CLARITY Act. Traders are deeply polarized, with many expressing frustration toward political leadership while others argue the regulatory setback is already priced in and view the dip as an accumulation opportunity.

Phathom Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of novel treatments for gastrointestinal diseases. The company was founded by Tadataka Yamada, David Socks, Azmi Nabulsi, Aditya Kohli, and Roger Ulrich on January 9, 2018 and is headquartered in Florham Park, NJ.

Phathom Pharmaceuticals Inc

Phathom Pharmaceuticals is trending as investors await upcoming earnings and evaluate recent institutional accumulation, with the community largely divided between frustration over persistent volatility and confidence in the long-term growth potential of its GI drug franchise. Many traders are focused on the company's path to profitability and potential for a future acquisition by a larger pharmaceutical player.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Baker Hughes Posts Upbeat Q2 Earnings, Joins Forte Biosciences, Eikon Therapeutics And Other Big Stocks Moving Higher On Monday

Dow Jones up 400 points on Monday. Baker Hughes Co (BKR) shares rise after positive earnings and technology order. Other big gainers include NIPG, FBRX, TRAX, GENI, BMNR, OMER, ASAN, EIKN, IONQ, and SPT.read more...

EIKN (NASDAQ:EIKN) Given Average Rating of "Moderate Buy" by Brokerages

EIKN (NASDAQ:EIKN - Get Free Report) has been assigned a consensus rating of "Moderate Buy" from the seven ratings firms that are currently covering the stock, MarketBeat.com reports. One investment analyst has rated the stock with a sell recommendation, one has issued a hold recommendation and...

EIKN (NASDAQ:EIKN) Lowered to Sell Rating by Wall Street Zen

Wall Street Zen downgraded shares of EIKN from a "hold" rating to a "sell" rating in a research report on Sunday...

Wedbush Reiterates Underperform Rating for EIKN (NASDAQ:EIKN)

Wedbush restated an "underperform" rating and set a $7.00 price target on shares of EIKN in a research report on Tuesday...

EIKN (NASDAQ:EIKN) Upgraded at Wall Street Zen

Wall Street Zen raised EIKN from a "sell" rating to a "hold" rating in a research note on Saturday...

EIKN (NASDAQ:EIKN) Given Consensus Rating of "Moderate Buy" by Brokerages

EIKN (NASDAQ:EIKN - Get Free Report) has been given a consensus recommendation of "Moderate Buy" by the seven ratings firms that are currently covering the company, MarketBeat reports. One investment analyst has rated the stock with a sell recommendation, one has issued a hold recommendation and...

EIKN's (NASDAQ:EIKN) Quiet Period Will Expire on March 17th

EIKN's (NASDAQ:EIKN - Get Free Report) quiet period will expire on Tuesday, March 17th. EIKN had issued 21,177,600 shares in its initial public offering on February 5th. The total size of the...

EIKN (NASDAQ:EIKN) Given Average Recommendation of "Moderate Buy" by Brokerages

Shares of EIKN (NASDAQ:EIKN - Get Free Report) have received an average rating of "Moderate Buy" from the six analysts that are currently covering the company, MarketBeat reports. One analyst has...

EIKN (NASDAQ:EIKN) Coverage Initiated by Analysts at Cantor Fitzgerald

Cantor Fitzgerald assumed coverage on shares of EIKN in a research report on Monday. They set an "overweight" rating for the company...

EIKN (NASDAQ:EIKN) Coverage Initiated by Analysts at JPMorgan Chase & Co.

JPMorgan Chase & Co. assumed coverage on shares of EIKN in a report on Monday. They issued an "overweight" rating and a $29.00 target price for the company...

Eikon Therapeutics is a biopharmaceutical company. It engages in the development of medicines for unmet medical needs. The company was founded in 2019 and is headquartered in Millbrae, CA.

Eikon Therapeutics Inc.

Neutral Sentiment

50bps hike

25bps hike

No change

25bps cut

The Federal Reserve's September FOMC meeting concludes Wednesday, September 16, with a rate decision due at 2:00 PM ET, following Tuesday's CPI report that showed inflation still running above the Fed's 2% target. What do you think the Fed decides at this week's FOMC meeting? Vote and explain your reasoning in the comments.

The Fed&#39;s rate decision comes Wednesday at 2PM ET. What do you think happens?

Feed

News

Sentiment

Earnings

Fundamentals

Info

EIKN Eikon Therapeutics Inc.

Fundamentals

Latest EIKN News